The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,570.00
Bid: 1,550.00
Ask: 1,590.00
Change: 0.00 (0.00%)
Spread: 40.00 (2.581%)
Open: 1,595.00
High: 1,595.00
Low: 1,570.00
Prev. Close: 1,570.00
CER Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

26 Jul 2007 11:13

Celtic Resources Holdings PLC26 July 2007 Celtic Resources Holdings Plc ("Celtic Resources" or "the Company") Purchase of remaining 25% of Zherek Gold Mine Celtic Resources is pleased to announce that it has purchased the remaining 25%of Zherek LLP for US$660,000 cash to take its ownership to 100%. The purchaseof the additional 25% in Zherek increases Celtic's total attributable gold resources by approximately 210,000 ounces gold to 4.23 million ounces gold. The 100% ownership of Zherek enables Celtic to develop Zherek as an integralpart of the Company's plans to consistently produce more than 100,000 oz/yearfrom their two Kazakhstan gold mines. Celtic's Suzdal and Zherek gold mines,separated by only 28km, can take advantage of their close proximity with thetreatment of the refractory components of the Zherek ore in the fullyfunctioning Suzdal BIOX plant. As of 1st January, 2006, Zherek had Measured, Indicated and Inferred sulphideore resources of 5.43 million tonnes at 4.8 g/t gold containing 841,000 ounces*.In 2006, gold production from the open pit and heap leach operation on oxide ores at Zherek was 9,735 oz, compared to 17,406 oz in 2005 as transitional oreswere encountered and recoveries and grades declined. Expected production in 2007is 10,000 ounces. Celtic is currently evaluating methods to treat the transitional ores in 2008and the sulphide ores in 2009 and expects the heap leaching of oxide ores tocontinue into 2008. Kevin Foo, Managing Director, commented, "Now we have 100% ownership of Zherek,we can focus on the next stage of planning to treat the substantial sulphideores in 2009, once the oxide ores are depleted. Test work and feasibility studies continue and we expect to have a decision on Zherek's optimumdevelopment route in early 2008." For further information please contact: Kevin Foo / Jonathan Scott-Barrett Jane Stacey / Leesa PetersCeltic Resources Holdings Plc Conduit PRTel: + 44 (0)20 7921 8800 Tel: +44 (0)20 7429 6606 / (0)792 292 3306Investors@celticresources.com jane@conduitpr.com Simon Raggett / Braden Saunders Peter KrensStrand Partners Limited Mirabaud Securities LimitedTel: +44 (0) 20 7409 3494 Tel: +44 (0)20 7878 3362 www.celticresources.com * Information extracted from an independent report prepared by SRK Consulting(UK) Ltd (SRK) which was prepared under the direction of Dr. Mike Armitage,CEng, CGeol. Dr Mike Armitage is a full time employee, and the ManagingDirector, of SRK and a Member of the Institute of Materials, Metals and Mining(IMMM) which is a Recognised Overseas Professional Organisation (ROPO) includedin a list promulgated by the Australian Stock Exchange from time to time. DrMike Armitage has sufficient experience which is relevant to the style ofmineralisation and type of deposit under consideration and to the activity whichhe is undertaking to qualify as a competent Person as defined in the 2004Edition of the Australasian Code for Reporting of Exploration Results, MineralResources and Ore Reserves. Dr Mike Armitage consents to the inclusion in thereport of the matters based on his information. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Apr 20247:00 amRNSTrading Update
13th Mar 20247:00 amRNSShare Purchase
13th Feb 20245:27 pmRNSTR-1 Notification
13th Feb 20245:22 pmRNSTR-1
1st Feb 20243:30 pmRNSResult of AGM
15th Dec 20234:15 pmRNSPosting of Annual Report and Notice of AGM
21st Nov 20235:34 pmRNSPDMR Shareholding
20th Nov 20237:00 amRNSFinal Results
17th Nov 20237:00 amRNSNotice of Results and Online Presentation
7th Nov 20237:00 amRNSLatest product release incorporates Generative AI
2nd Nov 20237:00 amRNSMajor new customer win with Tier-1 Telco
16th Oct 20237:00 amRNSTrading Update
25th Sep 202311:53 amRNSHolding(s) in Company
6th Jul 20237:00 amRNSCompletion of Initial Implementation at Telesur
21st Jun 20237:00 amRNSMajor new contract
22nd May 20237:00 amRNSGartner Market Guide Reports
15th May 20237:00 amRNSHalf-year Report
4th May 20237:00 amRNSDate of Interim Results and Investor Presentation
17th Apr 20237:00 amRNSH1 2023 Trading Update
31st Mar 20237:00 amRNSMajor New Contract
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:32 pmRNSHolding(s) in Company
21st Feb 20237:00 amRNSCompletion of Major Implementation
2nd Feb 20232:19 pmRNSResult of AGM
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20227:00 amRNSGrant of Options and PDMR Shareholding
15th Dec 20225:20 pmRNSHolding(s) in Company
2nd Dec 20222:35 pmRNSHolding(s) in Company
30th Nov 20226:29 pmRNSPDMR and PCA shareholding
30th Nov 202211:18 amRNSHolding(s) in Company
28th Nov 20227:00 amRNSFinal Results
23rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
2nd Nov 20225:49 pmRNSHolding(s) in Company
2nd Nov 202212:40 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSRelease of latest version of flagship product set
24th Oct 20227:00 amRNSTrading Update
6th Oct 20227:00 amRNSAppointment of Joint Broker
25th Aug 20223:48 pmRNSGrant of Options
8th Aug 20223:08 pmRNSHolding(s) in Company
28th Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20227:00 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSMajor Contract Win
13th May 20227:33 amRNSDirector Share Purchase
9th May 20227:00 amRNSInterim Results Presentation
9th May 20227:00 amRNSInterim Results
25th Apr 202210:13 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSH1 2022 Trading Update
6th Apr 20227:00 amRNSCerillion Client MVN-X Reaches Million Subscribers
7th Mar 20227:00 amRNSWins Prestigious Megabuyte Performance Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.